caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1881649101

Kanchana GattuM.D.

Interventional Pain ManagementBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kanchana Gattu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC42206
Seung Lee
Interventional Pain Management · Baltimore, MD
2792
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
23125
Ngozi Mewe-Pira
Nurse Practitioner · Baltimore, MD
2278
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1996
Lina Chen
Diagnostic Radiology · Baltimore, MD
1770
Univ Of Md Pathology Associates P A
Clinical Laboratory · Baltimore, MD
1584
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
367
Unique beneficiaries
—
Total services
649
Distinct HCPCS
11
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 35 Interventional Pain Management providers in MD — below median (cohort median 2,393).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
618
Beneficiaries
—
Total drug cost
$10K
Distinct drugs
14
Brand share
17.2%
Top prescribed drugs
Oxycodone Hcl118 claims
Gabapentin102 claims
Oxycodone Hcl/Acetaminophen72 claims
Cyclobenzaprine Hcl62 claims
Tramadol Hcl54 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$24
Payment records
1
By payment type
Food and Beverage$24